| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G | 2024-02-07 | ADAGE CAPITAL PARTNERS GP, L.L.C. | Solid Biosciences Inc. | 2,712,478 | 7.2% | EDGAR |
| SC 13G | 2024-01-22 | Artal International S.C.A. | Solid Biosciences Inc. | 2,717,538 | 7.3% | EDGAR |
| SC 13D/A | 2024-01-12 | BCLS SB Investco, LP | Solid Biosciences Inc. | 528,660 | 1.4% | EDGAR |
| SC 13D/A | 2024-01-12 | PERCEPTIVE ADVISORS LLC | Solid Biosciences Inc. | 6,925,028 | 18.6% | EDGAR |
| SC 13G | 2024-01-12 | Flynn James E | Solid Biosciences Inc. | 2,260,398 | 6.1% | EDGAR |
| SC 13D/A | 2024-01-11 | RA CAPITAL MANAGEMENT, L.P. | Solid Biosciences Inc. | 4,348,828 | 11.7% | EDGAR |
| SC 13D/A | 2024-01-10 | BCLS SB Investco, LP | Solid Biosciences Inc. | 528,660 | 2.6% | EDGAR |
| SC 13G/A | 2023-02-13 | SUVRETTA CAPITAL MANAGEMENT, LLC | Solid Biosciences Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2023-02-13 | K2 PRINCIPAL FUND, L.P. | Solid Biosciences Inc. | 284,871 | 1.5% | EDGAR |
| SC 13G/A | 2023-02-10 | EcoR1 Capital, LLC | Solid Biosciences Inc. | 0 | 0.0% | EDGAR |
| SC 13D/A | 2023-02-03 | PERCEPTIVE ADVISORS LLC | Solid Biosciences Inc. | 3,501,265 | 17.9% | EDGAR |
| SC 13G | 2022-12-12 | Camber Capital Management LP | Solid Biosciences Inc. | - | - | EDGAR |
| SC 13D/A | 2022-12-06 | PERCEPTIVE ADVISORS LLC | Solid Biosciences Inc. | 3,501,265 | 17.9% | EDGAR |
| SC 13D/A | 2022-12-05 | RA CAPITAL MANAGEMENT, L.P. | Solid Biosciences Inc. | 3,431,618 | 17.6% | EDGAR |
| SC 13D/A | 2022-12-05 | BCLS SB Investco, LP | Solid Biosciences Inc. | 528,661 | 2.7% | EDGAR |
| SC 13D/A | 2022-10-04 | RA CAPITAL MANAGEMENT, L.P. | Solid Biosciences Inc. | 12,447,873 | 11.0% | EDGAR |
| SC 13D/A | 2022-10-03 | BCLS SB Investco, LP | Solid Biosciences Inc. | 7,929,918 | 7.0% | EDGAR |
| SC 13D/A | 2022-09-06 | RA CAPITAL MANAGEMENT, L.P. | Solid Biosciences Inc. | 12,447,873 | 11.0% | EDGAR |
| SC 13D/A | 2022-09-02 | PERCEPTIVE ADVISORS LLC | Solid Biosciences Inc. | 13,462,552 | 11.9% | EDGAR |
| SC 13G | 2022-09-01 | K2 PRINCIPAL FUND, L.P. | Solid Biosciences Inc. | 5,709,200 | 5.0% | EDGAR |